Amedisys Inc.

NASDAQ: AMED · Real-Time Price · USD
100.99
0.01 (0.01%)
At close: Aug 14, 2025, 3:59 PM
101.00
0.01%
After-hours: Aug 14, 2025, 07:38 PM EDT

Amedisys Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
621.86M 594.78M 598.05M 587.67M 591.19M 571.41M 570.79M 556.24M 552.97M 556.39M 562.06M 557.99M 557.89M 545.26M 559.32M 553.49M 564.17M 537.14M
Cost of Revenue
130.32M 334.05M 344.61M 337.56M 460.64M 453.75M 140.6M 311.63M 297.45M 315.01M 317.17M 322.23M 316.21M 304.82M 317.17M 310.29M 308.69M 297.2M
Gross Profit
491.54M 260.73M 253.44M 250.11M 130.54M 117.66M 430.19M 244.61M 255.51M 241.38M 244.9M 235.76M 241.68M 240.44M 242.15M 243.19M 255.47M 239.94M
Operating Income
45.58M 43.36M -19.62M 30.33M 64.11M 52.29M 34.01M 42.21M 37.8M 42.38M 46.24M 38.93M 47.64M 47.96M 48.16M 56.77M 78.14M 68.85M
Interest Income
3.02M 2.87M 2.75M 2.02M 1.62M 1.73M 818K 1.3M 742K 406K 70K 59K 36K 13K n/a n/a 25K 24K
Pretax Income
48.33M 91.2M -19.23M 28.99M 49.23M 27.23M 29.2M 37.95M -62.23M 34.71M 41.34M 34.82M 40.36M 43.73M 46.88M 55.98M 109.17M 68.21M
Net Income
67.6M 61.01M -20.38M 41.46M 32.3M 14.4M 39.38M 25.96M -80.28M 25.25M 31.72M 25.64M 29.58M 31.67M 34.05M 45.01M 80.15M 49.87M
Selling & General & Admin
n/a 196.16M 202.7M 198.34M 195.75M 7.43M 197.04M 192.98M 212.99M 194.56M 193.43M 188.34M 187.82M 184.47M 184.85M 178.93M 175.22M 172.24M
Research & Development
n/a n/a n/a n/a n/a n/a 3.8M n/a n/a n/a 3M n/a n/a n/a n/a n/a n/a n/a
Other Expenses
576.28M 21.22M 70.36M 21.44M -58.6M -57.94M 536.78M 1.2M 4.74M 4.44M 5.23M 5.48M 6.22M 8.01M 492K 490K 475K 288K
Operating Expenses
576.28M 217.37M 273.06M 219.78M 66.43M 65.37M 536.78M 197.42M 217.72M 199M 198.66M 193.82M 194.04M 192.47M 193.99M 186.42M 177.34M 171.09M
Interest Expense
-6.42M 6.42M 6.98M 7.77M 7.89M 8.12M 8.23M 8.02M 7.5M 7.52M 5.78M 4.96M 8.31M 3.17M 2.79M 2.73M 1.93M 2.07M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -185.89M -2.66M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
706.61M 551.42M 617.68M 557.34M 527.07M 519.13M 677.38M 509.05M 515.17M 514.01M 515.83M 516.05M 510.25M 497.3M 511.16M 496.71M 486.03M 468.3M
Income Tax Expense
-19.27M 29.38M 6.29M -12.47M 16.66M 12.63M -10.18M 12.33M 18.25M 9.8M 9.79M 9.42M 11.32M 12.02M 12.87M 10.73M 28.55M 17.91M
Shares Outstanding (Basic)
32.85M 32.79M 32.72M 32.74M 32.71M 32.67M 32.63M 32.62M 32.58M 32.56M 32.51M 32.48M 32.52M 32.55M 32.59M 32.61M 32.59M 32.78M
Shares Outstanding (Diluted)
32.85M 33.22M 32.72M 33.13M 33.05M 32.98M 32.91M 32.83M 32.58M 32.64M 32.6M 32.62M 32.68M 32.77M 32.82M 32.9M 32.98M 33.19M
EPS (Basic)
2.06 1.86 -0.62 1.27 0.99 0.44 1.21 0.80 -2.46 0.78 0.98 0.79 0.91 0.97 1.04 1.38 2.46 1.52
EPS (Diluted)
2.06 1.84 -0.62 1.25 0.98 0.44 1.20 0.79 -2.46 0.77 0.97 0.79 0.91 0.97 1.04 1.37 2.43 1.50
EBITDA
46.28M 89.23M 3.16M 25.99M 70.47M 58.42M 43.32M 52.03M -48.53M 47.92M 52.35M 45.26M 54.89M 55.97M 57.3M 66.19M 117.82M 77.83M
EBIT
72.74M 84.78M -12.25M 21.21M 64.11M 52.29M 37.43M 45.97M -54.73M 42.23M 47.12M 39.78M 48.67M 47.96M 49.67M 58.71M 111.1M 70.28M
Depreciation & Amortization
4.37M 4.45M 15.41M 4.77M 6.36M 6.14M 5.89M 6.06M 6.2M 5.69M 5.23M 5.48M 6.22M 8.01M 9.14M 7.49M 6.72M 7.55M